Suchergebnisse - "McDonald, Craig M"

PubPharm (8)

1

Modeling Early Heterogeneous Rates of Progression in Boys with Duchenne Muscular Dystrophy

enthalten in: Journal of neuromuscular diseases | 2023

von Fang, Y. | McDonald, C. | Clemens, P. | +5

2

Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy : A Randomized Clinical Trial

enthalten in: JAMA neurology | 2022

von Guglieri, M. | Clemens, P. | Perlman, S. | +43

3

Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy : A 30-Month Nonrandomized Controlled Open-Label Extension Trial

enthalten in: JAMA network open | 2022

von Mah, J. | Clemens, P. | Guglieri, M. | +125

4

Deflazacort vs prednisone treatment for Duchenne muscular dystrophy : A meta-analysis of disease progression rates in recent multicenter clinical trials

enthalten in: Muscle & nerve | 2020

von McDonald, C. | Sajeev, G. | Yao, Z. | +10

5

Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function

enthalten in: Neurology | 2019

von Hoffman, E. | Schwartz, B. | Mengle-Gaw, L. | +28

6

Deflazacort versus prednisone/prednisolone for maintaining motor function and delaying loss of ambulation : A post HOC analysis from the ACT DMD trial

enthalten in: Muscle & nerve | 2018

von Shieh, P. | Mcintosh, J. | Jin, F. | +8

7

Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug

enthalten in: Pharmacological research | 2018

von Conklin, L. | Damsker, J. | Hoffman, E. | +29

8

Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study

enthalten in: Neurology | 2015

von Bello, L. | Gordish-Dressman, H. | Morgenroth, L. | +6

1
[1]